Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors

BACKGROUND: The National Comprehensive Cancer Network recommends either three cycles of bleomycin, etoposide, and cisplatin or four cycles of etoposide and cisplatin (EPx4) as initial chemotherapy for the treatment of good‐risk germ cell tumors (GCTs). To assess the response, toxicity, and survival...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Funt, Samuel A., McHugh, Deaglan J., Tsai, Stephanie, Knezevic, Andrea, O'Donnell, Devon, Patil, Sujata, Silber, Deborah, Bromberg, Maria, Carousso, Maryann, Reuter, Victor E., Carver, Brett S., Sheinfeld, Joel, Motzer, Robert J., Bajorin, Dean F., Bosl, George J., Feldman, Darren R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2021
Aiheet:
Genitourinary Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176973/
https://ncbi.nlm.nih.gov/pubmed/33586274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13719
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia